← Leaderboards
Issam Zineh
University Of Florida
$389,326
Attributed
$389,326
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $208.6K · FY2005–08$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$389,326 · 4
By mechanism
M01$389,326 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Julie A. Johnson$37,866,281
- Jatinder K. Lamba$4,761,475
- Stanley Barrett Pounds$2,845,206
- Emily Kate Plowman$5,716,576
- Courtney A Miller$16,288,628
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingAtherosclerosisAtorvastatinLipidsBlood VesselsCandidate Disease GeneCell WallChildhoodBaseAnti-InflammatoryComputer Retrieval Of Information On Scientific Projects DatabaseFunctional DisorderFundingGenesGenetic AssociationGrantHydroxymethylglutaryl-Coa Reductase InhibitorsImmunoregulationInflammationInflammatoryAnti-Inflammatory AgentsInstitutionIn VitroMiddle Age
Grant awards (4)
IMMUNO EFFECTS AND PHARMACOGEN OF ATORVASTATIN IN EARLY ATHEROSCLEROSIS$42,274
M01 · FY2008 · RR · contact PI
IMMUNO EFFECTS AND PHARMACOGEN OF ATORVASTATIN IN EARLY ATHEROSCLEROSIS$100,769
M01 · FY2007 · RR · contact PI
IMMUNO EFFECTS AND PHARMACOGEN OF ATORVASTATIN IN EARLY ATHEROSCLEROSIS$208,615
M01 · FY2006 · RR · contact PI
IMMUNO EFFECTS AND PHARMACOGEN OF ATORVASTATIN IN EARLY ATHEROSCLEROSIS$37,668
M01 · FY2005 · RR